Condition
Virus, Human Immunodeficiency
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04305977Not ApplicableWithdrawn
Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)
NCT02573376Not ApplicableCompleted
Antiviral Pharmacology and Adherence in Drug Users
NCT01570595Phase 1Completed
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
Showing all 3 trials